3/7/24 16:12 | 3/5/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 82 | 27 | 383 | D | | | | | | | | | | | | | | |
3/7/24 16:12 | 3/5/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | S.d | -1,352 | 13.52 | 0 | -100 | -21 | 383 | D | | | | | | | | | | | | | | |
3/5/24 16:12 | 3/3/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 58 | 17 | 401 | D | | | | | | | | | | | | | | |
3/1/24 06:52 | 2/28/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 21 | 6 | 342 | D | | | | | | | | | | | | | | |
3/7/23 16:11 | 3/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 73 | 29 | 322 | D | | | | | | | | | | | | | | |
3/2/23 07:36 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 71 | 40 | 248 | D | | | | | | | | | | | | | | |
3/8/22 16:11 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 83 | 88 | 178 | D | | | | | | | | | | | | | | |
3/2/22 07:50 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 21 | 28 | 95 | D | | | | | | | | | | | | | | |
2/10/22 16:10 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 16 | 27 | 74 | D | | | | | | | | | | | | | | |
5/13/21 07:46 | 5/11/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 38 | 184 | 58 | D | | | | | | | | | | | | | | |
3/17/21 16:03 | 3/16/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | S | -1,428 | 11.22 | 0 | -127 | -86 | 21 | D | | | | | | | | | | | | | | |
3/8/21 16:11 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 16 | 12 | 148 | D | | | | | | | | | | | | | | |
3/2/21 16:08 | 2/28/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 21 | 19 | 132 | D | | | | | | | | | | | | | | |
2/17/21 16:08 | 2/14/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 6 | 5 | 111 | D | | | | | | | | | | | | | | |
2/11/21 16:10 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 16 | 17 | 106 | D | | | | | | | | | | | | | | |
2/18/20 07:25 | 2/13/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | S.d | -940 | 13.03 | 0 | -72 | -74 | 25 | D | | | | | | | | | | | | | | |
2/18/20 07:25 | 2/14/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
2/11/20 07:03 | 2/9/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 16 | 27 | 72 | D | | | | | | | | | | | | | | |
2/19/19 07:19 | 2/14/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 6 | 11 | 57 | D | | | | | | | | | | | | | | |
2/20/18 08:31 | 2/14/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Glob | S.m | -99 | 19.68 | 0 | -5 | -11 | 42 | D | | | | | | | | | | | | | | |